1st Quarter - Report — NATIONAL MARROW DONOR PROGRAM for NATIONAL MARROW DONOR PROGRAM (2014)

Firm

NATIONAL MARROW DONOR PROGRAM

Client

NATIONAL MARROW DONOR PROGRAM

Income

—

Expenses

$77,248

Expense method

B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Implementation of P.L. 111-148 Patient Protection and Affordable Care Act; H.R. 589 To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes; HRSA Proposed Rule: Change to the Definition of Human Organ Under Section 301 of the National Organ Transplant Act of 1984

Lobbyist	Covered position, as disclosed
CHAD RAMSEY	—

Contacted: SENATE; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 589 (113th)

Budget/Appropriations BUD

Department of Defense and Department of Health and Human Services FY 2014 Appropriations for C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory;

Lobbyist	Covered position, as disclosed
CHAD RAMSEY	—

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare coverage and reimbursement for bone marrow and cord blood transplantation

Lobbyist	Covered position, as disclosed
CHAD RAMSEY	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.